These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 3036324)
21. Regression of cardiac hypertrophy with drug treatment in spontaneously hypertensive rats. Ruskoaho H Med Biol; 1984; 62(5):263-76. PubMed ID: 6152298 [TBL] [Abstract][Full Text] [Related]
22. [Function and role of the sarcoplasmic reticulum in heart disease]. Reyes-Juárez JL; Zarain-Herzberg A Arch Cardiol Mex; 2006; 76 Suppl 4():S18-32. PubMed ID: 17469332 [TBL] [Abstract][Full Text] [Related]
23. [Various characteristics of the contractile function of the heart in cardiac hypertrophy during readaptation after adaptation of the body to high-altitude hypoxia]. Varosian MA; Martirosian MF; Tatinian NG; Petrosian VP Kosm Biol Aviakosm Med; 1990; 24(6):42-5. PubMed ID: 2149867 [TBL] [Abstract][Full Text] [Related]
24. Enhanced sarcolemmal Ca2+ efflux reduces sarcoplasmic reticulum Ca2+ content and systolic Ca2+ in cardiac hypertrophy. Díaz ME; Graham HK; Trafford AW Cardiovasc Res; 2004 Jun; 62(3):538-47. PubMed ID: 15158146 [TBL] [Abstract][Full Text] [Related]
25. Reduced myocardial sarcoplasmic reticulum Ca(2+)-ATPase protein expression in compensated primary and secondary human cardiac hypertrophy. Schotten U; Koenigs B; Rueppel M; Schoendube F; Boknik P; Schmitz W; Hanrath P J Mol Cell Cardiol; 1999 Aug; 31(8):1483-94. PubMed ID: 10423346 [TBL] [Abstract][Full Text] [Related]
29. Phosphatase inhibitor-1-deficient mice are protected from catecholamine-induced arrhythmias and myocardial hypertrophy. El-Armouche A; Wittköpper K; Degenhardt F; Weinberger F; Didié M; Melnychenko I; Grimm M; Peeck M; Zimmermann WH; Unsöld B; Hasenfuss G; Dobrev D; Eschenhagen T Cardiovasc Res; 2008 Dec; 80(3):396-406. PubMed ID: 18689792 [TBL] [Abstract][Full Text] [Related]
30. [Physiopathology of cardiac insufficiency. Biological factors of adaptation and disadaptation of the heart to chronic mechanical overload]. Swynghedauw B Schweiz Med Wochenschr; 1995 Feb; 125(7):288-93. PubMed ID: 7878407 [TBL] [Abstract][Full Text] [Related]
31. Role of subcellular remodeling in cardiac dysfunction due to congestive heart failure. Babick AP; Dhalla NS Med Princ Pract; 2007; 16(2):81-9. PubMed ID: 17303941 [TBL] [Abstract][Full Text] [Related]
32. Hypertrophy without contractile dysfunction after reversal of pressure overload in the cat. Wisenbaugh T; Allen P; Cooper G; O'Connor WN; Mezaros L; Streter F; Bahinski A; Houser S; Spann JF Am J Physiol; 1984 Jul; 247(1 Pt 2):H146-54. PubMed ID: 6234811 [TBL] [Abstract][Full Text] [Related]
33. [Role of adrenergic receptor system in cardiac overload]. Toshima H; Shida M Tanpakushitsu Kakusan Koso; 1990 Jul; 35(10):1759-66. PubMed ID: 2173031 [No Abstract] [Full Text] [Related]
35. Some biochemical lesions in myocardial disease. Sordahl LA Tex Rep Biol Med; 1979; 38():121-35. PubMed ID: 161081 [No Abstract] [Full Text] [Related]
36. [Biochemical problems in cardiac hypertrophy and chronic insufficiency]. Swynghedauw B Nouv Presse Med; 1979 Oct; 8(38):3021-4. PubMed ID: 160541 [No Abstract] [Full Text] [Related]
37. [Myocardial structure in various forms of hypertrophy. I. Myocyte hypertrophy or hyperplasia? Pathophysiological aspects and the methods of study]. Grajek S; Paradowski S; Zajac M; Kaczmarek E Kardiol Pol; 1990; 33(6):375-83. PubMed ID: 2150679 [TBL] [Abstract][Full Text] [Related]
38. Pathogenesis of ventricular hypertrophy. Oparil S J Am Coll Cardiol; 1985 Jun; 5(6 Suppl):57B-65B. PubMed ID: 3158693 [TBL] [Abstract][Full Text] [Related]
39. The cardiac hypertrophic responses to pathologic and physiologic loads. Scheuer J; Buttrick P Circulation; 1987 Jan; 75(1 Pt 2):I63-8. PubMed ID: 2947753 [TBL] [Abstract][Full Text] [Related]